Re: Sarcopenia is a Poor Prognostic Factor of Castration-Resistant Prostate Cancer Treated with Docetaxel Therapy
Abstract
No AccessJournal of UrologyUrological Survey1 Jan 2020Re: Sarcopenia is a Poor Prognostic Factor of Castration-Resistant Prostate Cancer Treated with Docetaxel Therapy Tomas L. GrieblingMD, MPH Tomas L. GrieblingTomas L. Griebling More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000604840.21681.4bAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked...
Paper Details
Title
Re: Sarcopenia is a Poor Prognostic Factor of Castration-Resistant Prostate Cancer Treated with Docetaxel Therapy
Published Date
Jan 1, 2020
Journal
Volume
203
Issue
1
Pages
10 - 11
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History